Holen Sie sich die Stockscreener-App
4.61
1.99%
0.09
Handel nachbörslich:
4.63
0.02
+0.43%
Recursion Pharmaceuticals Inc Aktie (RXRX) Neueste Nachrichten
Ranking Recursion Pharmaceuticals Inc. among high performing stocks via toolsSwing Trade & Daily Price Action Insights - Newser
Recursion Pharmaceuticals Stock (RXRX) Opinions on AI-Driven Pipeline Updates - Quiver Quantitative
Tools to assess Recursion Pharmaceuticals Inc.’s risk profileJuly 2025 Opening Moves & Consistent Income Trade Ideas - Newser
Real time pattern detection on Recursion Pharmaceuticals Inc. stockProfit Target & Fast Gain Swing Trade Alerts - Newser
Applying Wyckoff theory to Recursion Pharmaceuticals Inc. stockQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - Newser
Using Ichimoku Cloud for Recursion Pharmaceuticals Inc. technicalsEarnings Trend Report & Precise Swing Trade Entry Alerts - Newser
Analyzing recovery setups for Recursion Pharmaceuticals Inc. investors2025 AllTime Highs & Real-Time Chart Breakout Alerts - Newser
Real time alert setup for Recursion Pharmaceuticals Inc. performanceBond Market & Free Community Consensus Stock Picks - Newser
Detecting support and resistance levels for Recursion Pharmaceuticals Inc.CEO Change & High Win Rate Trade Tips - Newser
Multi asset correlation models including Recursion Pharmaceuticals Inc.2025 Pullback Review & Expert Approved Momentum Ideas - Newser
How to read the order book for Recursion Pharmaceuticals Inc.Market Weekly Review & Verified Swing Trading Watchlist - Newser
Will Recursion Pharmaceuticals Inc. stock recover after recent drop2025 Technical Patterns & Reliable Price Action Trade Plans - Newser
Historical volatility pattern of Recursion Pharmaceuticals Inc. visualizedGold Moves & Weekly Chart Analysis and Guides - Newser
Volatility clustering patterns for Recursion Pharmaceuticals IncJuly 2025 Breakouts & High Yield Equity Trading Tips - Newser
Chart based exit strategy for Recursion Pharmaceuticals Inc.2025 Institutional Moves & Real-Time Volume Analysis - Newser
Recursion Pharmaceuticals Inc. stock prediction for this weekJuly 2025 Big Picture & Weekly Market Pulse Updates - Newser
Can Recursion Pharmaceuticals Inc. rally from current levels2025 Price Momentum & AI Forecasted Entry and Exit Points - Newser
How to escape a deep drawdown in Recursion Pharmaceuticals Inc.Portfolio Return Report & Free Expert Approved Momentum Trade Ideas - Newser
S P Trends: Will Recursion Pharmaceuticals Inc. outperform tech stocksRecession Risk & Technical Entry and Exit Alerts - خودرو بانک
What’s the recovery path for long term holders of Recursion Pharmaceuticals Inc.Quarterly Profit Report & Risk Managed Investment Strategies - Newser
Will Recursion Pharmaceuticals Inc. see short term momentumIPO Watch & Real-Time Chart Pattern Alerts - Newser
Will Recursion Pharmaceuticals Inc. benefit from current market trends2025 Risk Factors & High Accuracy Swing Trade Signals - خودرو بانک
Is Recursion Pharmaceuticals Inc. in a long term uptrendInsider Buying & Safe Capital Growth Trade Ideas - خودرو بانک
Will Recursion Pharmaceuticals Inc. benefit from macro trendsMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Applying chart zones and confluence areas to Recursion Pharmaceuticals Inc.2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Forecasting Recursion Pharmaceuticals Inc. price range with options dataWeekly Profit Summary & Weekly High Conviction Trade Ideas - Newser
Is Recursion Pharmaceuticals Inc. a strong growth stockJuly 2025 Trade Ideas & Consistent Growth Equity Picks - خودرو بانک
Tools to monitor Recursion Pharmaceuticals Inc. recovery probability2025 Volatility Report & AI Driven Stock Movement Reports - Newser
Can technical indicators confirm Recursion Pharmaceuticals Inc.’s reversalAnalyst Upgrade & Real-Time Stock Entry Alerts - Newser
Can Recursion Pharmaceuticals Inc. hit a new high this monthTrade Analysis Summary & Verified Entry Point Detection - Newser
Visualizing Recursion Pharmaceuticals Inc. stock with heatmapsJuly 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
Recursion Pharmaceuticals' Strategic Position in TechBio and Clinical Pipeline Progress - AInvest
Pattern recognition hints at Recursion Pharmaceuticals Inc. upsideLayoff News & Safe Entry Point Alerts - Newser
Is Recursion Pharmaceuticals Inc. trending in predictive chart models2025 Investor Takeaways & High Accuracy Swing Entry Alerts - Newser
Aug Update: What is the Moat Score of Recursion Pharmaceuticals Inc.Risk Management & Low Volatility Stock Suggestions - خودرو بانک
Technical analysis overview for Recursion Pharmaceuticals Inc. stockJuly 2025 Momentum & Safe Investment Capital Preservation Plans - Newser
How liquid is Recursion Pharmaceuticals Inc. stock2025 Investor Takeaways & Free High Accuracy Swing Entry Alerts - خودرو بانک
Can machine learning forecast Recursion Pharmaceuticals Inc. recoveryJuly 2025 Summary & Fast Momentum Entry Tips - Newser
Recursion Pharmaceuticals shares rise 1.93% premarket as AI-driven drug discovery gains traction. - AInvest
Is now a turning point for Recursion Pharmaceuticals Inc.Weekly Trade Recap & Precise Trade Entry Recommendations - Newser
Layoff Tracker: Novartis Continues Cutting Spree With 58 Sacked in New Jersey - BioSpace
What’s next for Recursion Pharmaceuticals Inc. stock priceJuly 2025 Big Picture & Safe Entry Point Identification - Newser
AI-driven drug discovery picks up as FDA pushes to reduce animal testing - Reuters
Combining price and volume data for Recursion Pharmaceuticals Inc.July 2025 Snapshot & Fast Moving Stock Watchlists - Newser
Should I buy Recursion Pharmaceuticals Inc. stock nowJuly 2025 Weekly Recap & Consistent Profit Alerts - خودرو بانک
How to manage a losing position in Recursion Pharmaceuticals Inc.July 2025 Market Mood & Risk Managed Investment Strategies - Newser
How high can Recursion Pharmaceuticals Inc. stock goEarnings Overview Summary & Long-Term Safe Investment Plans - Newser
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):